Moderna Announces the European Commission's Approval of Advance Purchase Agreement for Initial 80 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)Business Wire • 11/25/20
Moderna chief medical officer: Vaccinated adults could still infect the unvaccinated with COVID-19Fast Company • 11/24/20
With 2 Effective Coronavirus Vaccine Candidates, How Should Investors Proceed?The Motley Fool • 11/23/20
Moderna's CEO sold nearly $2 million of his stock ahead of the company's emergency use vaccine filing. He's now worth $3 billion.Business Insider • 11/23/20
Coronavirus vaccine czar said Moderna will seek an emergency use authorization for its vaccine by the end of NovemberBusiness Insider • 11/22/20